BIOMAT Database Logo BIOMAT Database Logo

The cGAS-STING pathway: a therapeutic target in chromosomally unstable cancers. 2023

Haiyan Yan, and Weiguo Lu, and Fangwei Wang
Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, 310015, Hangzhou, China. yanhy@zucc.edu.cn.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009713 Nucleotidyltransferases A class of enzymes that transfers nucleotidyl residues. EC 2.7.7. Nucleotidyltransferase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Haiyan Yan, and Weiguo Lu, and Fangwei Wang
cGAS-STING and the deadly CIN: how chronic inflammation represents a therapeutic vulnerability in chromosomally unstable cancers.
October 2022, Trends in cancer,
Haiyan Yan, and Weiguo Lu, and Fangwei Wang
The cGAS-STING pathway as a therapeutic target in inflammatory diseases.
September 2021, Nature reviews. Immunology,
Haiyan Yan, and Weiguo Lu, and Fangwei Wang
The cGAS-STING pathway: a therapeutic target in diabetes and its complications.
January 2024, Burns & trauma,
Haiyan Yan, and Weiguo Lu, and Fangwei Wang
The cGAS-STING Pathway: A Promising Immunotherapy Target.
January 2021, Frontiers in immunology,
Haiyan Yan, and Weiguo Lu, and Fangwei Wang
cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers.
July 2022, Nature,
Haiyan Yan, and Weiguo Lu, and Fangwei Wang
The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma.
February 2020, Oncogene,
Haiyan Yan, and Weiguo Lu, and Fangwei Wang
The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
January 2021, Frontiers in immunology,
Haiyan Yan, and Weiguo Lu, and Fangwei Wang
Cancer immunotherapy strategies that target the cGAS-STING pathway.
January 2022, Frontiers in immunology,
Haiyan Yan, and Weiguo Lu, and Fangwei Wang
cGAS-STING signaling pathway in gastrointestinal inflammatory disease and cancers.
January 2022, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Haiyan Yan, and Weiguo Lu, and Fangwei Wang
cGAS-STING Pathway as the Target of Immunotherapy for Lung Cancer.
January 2023, Current cancer drug targets,
Copied contents to your clipboard!